Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TT0C8BY)

• DTT Name: Plasma retinol-binding protein (RBP4) DTT Info
• Gene Name: RBP4

Molecule-Related Drug & Molecule List

1 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Tinlarebant	DM6JYUO	Stargardt disease	9B70	Phase 3	[1]

11 Patented Agent(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
A1-10436	DM9ESPR	N. A.	N. A.	Patented	[2]
A1-10438	DMJD1S6	N. A.	N. A.	Patented	[2]
US8586571, 12	DMKLJ6O	N. A.	N. A.	Patented	[3]
US8586571, 36	DMX3A0O	N. A.	N. A.	Patented	[3]
US8586571, 6	DM1N74R	N. A.	N. A.	Patented	[3]
US8853215, 3	DMX8NLB	N. A.	N. A.	Patented	[2]
US9434727, 120	DMIT0H3	N. A.	N. A.	Patented	[4]
US9434727, 153	DMC812I	N. A.	N. A.	Patented	[4]
US9434727, 40	DMLPWK3	N. A.	N. A.	Patented	[5]
US9434727, 63	DM9HQXC	N. A.	N. A.	Patented	[4]
US9434727, 93	DMCJG8Z	N. A.	N. A.	Patented	[6]

References

• [1] Retinol binding protein 4 antagonists and protein synthesis inhibitors: Potential for therapeutic development. Eur J Med Chem. 2021 Dec 15;226:113856.
• [2] Derivatives of N-acyl-N-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes. US8853215.
• [3] Heterocyclic compound. US8586571.
• [4] Substituted 4-phenylpiperidines, their preparation and use. US9434727.
• [5] Substituted 4-phenylpiperidines, their preparation and use. US9777010.
• [6] Substituted 4-phenylpiperidines, their preparation and use. US10072016.